Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis by Mega, Jessica L, Dr, Close, Sandra L, PhD, Wiviott, Stephen D, MD, Shen, Lei, PhD, Walker, Joseph R, PharmD, Simon, Tabassome, Prof, Antman, Elliott M, Prof, Braunwald, Eugene, Prof, Sabatine, Marc S, Dr

Get full text

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial by Mega, Jessica L, Dr, Walker, Joseph R, PharmD, Ruff, Christian T, MD, Vandell, Alexander G, PhD, Nordio, Francesco, PhD, Deenadayalu, Naveen, MPH, Murphy, Sabina A, MPH, Lee, James, PhD, Mercuri, Michele F, MD, Giugliano, Robert P, MD, Antman, Elliott M, Prof, Braunwald, Eugene, Prof, Sabatine, Marc S, Dr Prof

Get full text

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial by Sabatine, Marc S, Dr, Antman, Elliott M, Prof, Widimsky, Petr, Prof, Ebrahim, Iftikhar O, MBBCh, Kiss, Robert G, MD, Saaiman, André, MD, Polasek, Rostislav, MD, Contant, Charles F, PhD, McCabe, Carolyn H, BS, Braunwald, Eugene, Prof

Get full text

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials by Mega, Jessica L, Dr, Stitziel, Nathan O, Dr, Smith, J Gustav, MD, Chasman, Daniel I, PhD, Caulfield, Mark J, Prof, Devlin, James J, PhD, Nordio, Francesco, PhD, Hyde, Craig L, PhD, Cannon, Christopher P, Prof, Sacks, Frank M, Prof, Poulter, Neil R, Prof, Sever, Peter S, Prof, Ridker, Paul M, Prof, Braunwald, Eugene, Prof, Melander, Olle, Prof, Kathiresan, Sekar, MD, Sabatine, Marc S, Prof

Get full text

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LA... by Giugliano, Robert P, Dr, Desai, Nihar R, MD, Kohli, Payal, MD, Rogers, William J, Prof, Somaratne, Ransi, MD, Huang, Fannie, MS, Liu, Thomas, PhD, Mohanavelu, Satishkumar, MS, Hoffman, Elaine B, PhD, McDonald, Shannon T, BSN, Abrahamsen, Timothy E, BA, Wasserman, Scott M, MD, Scott, Robert, MD, Sabatine, Marc S, MD

Get full text

Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial by Scirica, Benjamin M, Dr, Bonaca, Marc P, MD, Braunwald, Eugene, Prof, De Ferrari, Gaetano M, MD, Isaza, Daniel, MD, Lewis, Basil S, Prof, Mehrhof, Felix, MD, Merlini, Piera A, Prof, Murphy, Sabina A, MPH, Sabatine, Marc S, MD, Tendera, Michal, Prof, Van de Werf, Frans, Prof, Wilcox, Robert, Prof, Morrow, David A, MD

Get full text

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials by O'Donoghue, Michelle L, Dr, Braunwald, Eugene, Prof, Antman, Elliott M, Prof, Murphy, Sabina A, MPH, Bates, Eric R, Prof, Rozenman, Yoseph, Prof, Michelson, Alan D, MD, Hautvast, Raymond W, MD, Ver Lee, Peter N, MD, Close, Sandra L, PhD, Shen, Lei, PhD, Mega, Jessica L, MD, Sabatine, Marc S, MD, Wiviott, Stephen D, MD

Get full text